Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (ISRCTN46157068) titled 'Identifying candidates for early respiratory failure treatment based on Interleukin-6 levels' on Oct. 9.
Study Type: Interventional
Study Design:
Single-centre Phase II randomized controlled pilot feasibility study (Other, Treatment)
Primary Sponsor: University Health Network
Condition:
Acute hypoxemic respiratory failure
Respiratory
Intervention:
Patient's blood IL-6 levels will be measured at 2 timepoints, with samples taken 24-48 hours apart. Patients will be monitored for 28 days, or until discharge from hospital, and data will be gathered from their medical charts.
Patients with elevated IL-6 levels...